Log in

Corbus Pharmaceuticals Earnings Date, Estimates & History

-0.03 (-2.88 %)
(As of 10/23/2020 12:00 AM ET)
Today's Range
Now: $1.01
50-Day Range
MA: $2.34
52-Week Range
Now: $1.01
Volume2.48 million shs
Average Volume2.37 million shs
Market Capitalization$82.53 million
P/E RatioN/A
Dividend YieldN/A


Corbus Pharmaceuticals (NASDAQ:CRBP) Earnings Information

Corbus Pharmaceuticals last issued its quarterly earnings data on August 6th, 2020. The biopharmaceutical company reported ($0.52) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.39) by $0.13. The firm had revenue of $0.29 million for the quarter, compared to analysts' expectations of $3.90 million. Corbus Pharmaceuticals has generated ($1.12) earnings per share over the last year. Corbus Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 5th, 2020 based off prior year's report dates.

Corbus Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Corbus Pharmaceuticals (NASDAQ:CRBP) Earnings Estimates

2020 EPS Consensus Estimate: ($1.26)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.33)($0.33)($0.33)
Q2 20201($0.34)($0.34)($0.34)
Q3 20202($0.34)($0.30)($0.32)
Q4 20202($0.31)($0.22)($0.27)

Corbus Pharmaceuticals (NASDAQ CRBP) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/6/20206/30/2020($0.39)($0.52)($0.52)$3.90 million$0.29 millionTranscript
5/11/20203/31/2020($0.40)($0.43)($0.43)$1.64 million$1.76 millionTranscript
3/12/202012/31/2019($0.36)($0.41)($0.41)$4.64 million$2.57 millionTranscript
11/7/2019Q3($0.36)($0.32)($0.32)$1.73 million$2.59 millionListen
8/8/2019Q2 2019($0.22)$0.03$0.03$10.32 million$29.10 millionN/A
5/9/20193/31/2019$0.02($0.43)($0.43)$20.97 million$1.89 millionN/A
3/12/201912/31/2018($0.23)($0.30)($0.30)$1.99 million$1.93 millionN/A
11/8/20189/30/2018($0.21)($0.26)($0.26)$1.66 million$1.09 millionN/A
8/8/2018Q2 2018($0.2150)($0.21)($0.21)$1.90 million$0.85 millionN/A
5/10/2018Q1 2018($0.10)($0.21)($0.21)$6.25 million$0.95 millionN/A
3/12/2018Q4 2017($0.1550)($0.20)($0.20)N/A
11/8/2017Q3 2017($0.16)($0.14)($0.14)$0.80 millionN/A
8/9/2017Q2 2017($0.19)($0.15)($0.15)$0.50 million$0.35 millionN/A
5/9/2017Q1 2017($0.16)($0.16)($0.16)$2.50 million$1.29 millionN/A
3/9/2017Q4 2016($0.1220)($0.18)($0.18)$1.50 million$0.38 millionN/A
11/10/2016Q3 2016($0.10)($0.12)($0.12)$1.00 million$0.74 millionN/A
8/15/2016Q216($0.08)($0.11)($0.11)$1.25 million$0.40 millionN/A
5/16/2016Q116($0.08)($0.08)($0.08)$0.40 millionN/A
3/29/2016Q4 2015($0.06)($0.06)($0.06)$1.25 million$0.36 millionN/A
11/10/2015Q315($0.08)($0.06)($0.06)$0.17 millionN/A
8/13/2015Q2 2015($0.06)($0.10)($0.10)$0.11 millionN/A
5/13/2015Q1 2015($0.05)($0.06)($0.06)N/A
2/10/2015Q4 2014($0.03)($0.06)($0.06)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 10/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.